Ready for Safe Cancer Treatment (RESET): A Comprehensive Perioperative Program for Surgical Oncology
NCT07727876 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12800
Last updated 2026-07-27
Summary
The goal of this randomized controlled clinical trial is to evaluate whether the Ready for Safe Cancer Treatment (RESET) program improves perioperative care and supports safe hospital discharge in two surgical populations: adult patients undergoing planned oncological surgery and patients aged 70 years or older undergoing planned non-oncological surgery under general anesthesia.
RESET is a comprehensive, multidisciplinary care pathway that combines prehabilitation, standardized perioperative care, enhanced recovery, and individualized transitional care after discharge.
The main questions it aims to answer are:
Does the RESET program reduce postoperative complications, prolonged hospitalizations, and unplanned rehospitalizations after oncological and non-oncological surgery?
Does the RESET program improve patients' overall health status, physical function, quality of life, perioperative safety, and recovery?
Does implementation of RESET improve the organization and efficiency of hospital care while reducing healthcare resource utilization and costs?
Researchers will compare patients receiving the RESET program with patients receiving standard perioperative care to determine whether the comprehensive intervention leads to improved clinical, organizational, and patient-reported outcomes.
Participants assigned to the RESET intervention will:
undergo a comprehensive multidisciplinary prehabilitation assessment performed by a physician, physiotherapist, dietitian, psychologist, clinical pharmacist, nurse, and study coordinator;
receive an individualized prehabilitation program that may include physical exercise, nutritional support, psychological support, medication optimization, and patient education before surgery;
use a dedicated RESET mobile application to communicate with the multidisciplinary prehabilitation team, ask questions, receive individualized recommendations and information, follow the schedule of visits and planned activities, and support adherence to the intervention;
undergo reassessment of their health status, needs, and implementation of recommendations on the day of hospital admission, allowing barriers to be identified and the perioperative care plan to be optimized;
receive standardized in-hospital perioperative care incorporating Enhanced Recovery After Surgery principles, the SAFER Patient Flow Bundle, the Red2Green methodology, medication review by a clinical pharmacist, and coordinated multidisciplinary care;
receive an individualized transitional care plan after discharge, including follow-up support and monitoring for complications and rehospitalization.
Participants in the control group will receive standard perioperative care according to routine clinical practice at the participating hospitals.
The study will evaluate clinical outcomes, including postoperative complications, prolonged hospitalization, rehospitalization, recovery, overall health status, physical function, and quality of life. It will also evaluate patient satisfaction, adherence to the RESET pathway, organizational effectiveness, and costs associated with implementation of RESET.
The results are expected to support the development of an evidence-based and scalable perioperative care model that can be used in oncological surgery and in older patients undergoing major non-oncological surgery.
Conditions
- Neoplasms
- Frailty
- Surgical Procedures, Operative
Interventions
- OTHER
-
RESET multimodal perioperative care pathway
RESET is a standardized, individualized, multidisciplinary perioperative care pathway delivered from approximately 21±7 days before surgery through 30-day follow-up. It includes: (1) preoperative assessment and personalized prehabilitation addressing nutrition, physical activity, psychological support, and medication optimization; (2) care coordination and communication with the prehabilitation team, supported by the RESET mobile application; (3) reassessment on hospital admission and coordinated perioperative planning; (4) enhanced recovery during hospitalization, including early mobilization, nutritional support, pain management, the SAFER Patient Flow Bundle, and Red-to-Green review; and (5) individualized discharge planning and transitional care. Components are tailored to the participant's clinical status, functional capacity, nutritional and psychological needs, comorbidities, and planned surgery.
- OTHER
-
Standard perioperative care
Participants receive standard perioperative care according to routine practice at the participating hospital. This includes usual surgical and anesthetic qualification, preoperative tests and consultations when clinically indicated, routine inpatient surgical and postoperative care, discharge instructions, and standard follow-up. Participants do not receive the coordinated multidisciplinary RESET pathway or individualized RESET recommendations. Protocol-defined assessments and activity monitoring are performed in both study arms for research purposes and are not components of the comparator intervention.
Sponsors & Collaborators
-
Łukasiewicz Research Network - PORT Polish Center for Technology Development
collaborator UNKNOWN -
4th Military Clinical Hospital with Polyclinic, Poland
collaborator OTHER -
Regional Specialist Hospital in Wroclaw
lead OTHER
Principal Investigators
-
Małgorzata Wierzbicka, Professor · Regional Specialist Hospital in Wroclaw
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-16
- Primary Completion
- 2030-05-16
- Completion
- 2031-07-31
Countries
- Poland
Study Locations
More Related Trials
-
Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life
NCT01367795 ·Status: COMPLETED
-
Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
NCT02741167 ·Status: UNKNOWN
-
Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery
NCT03299270 ·Status: UNKNOWN
-
Sepsis in Oncology Patients
NCT06046677 ·Status: NOT_YET_RECRUITING
-
A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds
NCT02431741 ·Status: COMPLETED ·Phase: NA
-
Validation of the European Oncology Quality of Life Toolkit
NCT05947903 ·Status: NOT_YET_RECRUITING
-
Study Assessing the Safety and Performance of Smart Matrix®
NCT03742726 ·Status: UNKNOWN ·Phase: NA
-
Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.
NCT02921724 ·Status: UNKNOWN ·Phase: NA
-
Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
NCT05267912 ·Status: RECRUITING ·Phase: NA
-
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
NCT06967961 ·Status: RECRUITING ·Phase: NA
-
Cancer-related Thromboembolic Disease
NCT02785757 ·Status: UNKNOWN ·Phase: NA
-
High Definition Medicine for Solid Tumors Oncology
NCT06590506 ·Status: RECRUITING
-
Analysis of Palliative Surgery in View of Quality of Life and Prognosis
NCT00690391 ·Status: UNKNOWN
-
Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells
NCT05486273 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors
NCT02662621 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
NCT00707161 ·Status: TERMINATED ·Phase: PHASE2
-
Research Collaboration for a Precision Oncology Program (POP)
NCT06680726 ·Status: RECRUITING
-
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
NCT07215611 ·Status: RECRUITING
-
Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma
NCT03062410 ·Status: UNKNOWN ·Phase: NA
-
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
NCT07404605 ·Status: RECRUITING ·Phase: NA
-
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
NCT06753136 ·Status: RECRUITING ·Phase: NA
-
Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia
NCT03743961 ·Status: TERMINATED
-
Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities
NCT01013168 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Analgesia aNd caNcer recUrrence Lung cAncer Resection
NCT04656769 ·Status: COMPLETED
-
Minimal Residual Disease in Solid Malignancies
NCT07268469 ·Status: NOT_YET_RECRUITING ·Phase: NA